Treatment of recurrent pediatric myelodysplastic syndrome post hematopoietic stem cell transplantation.
Clin Case Rep
; 11(11): e8190, 2023 Nov.
Article
in En
| MEDLINE
| ID: mdl-38028059
ABSTRACT
Treatment of recurrent myelodysplastic syndrome (MDS) after hematopoietic cell transplantation (HCT) remains challenging. We present a 4-year-old girl experiencing early MDS relapse post-HCT treated with a multimodal strategy encompassing a second HCT and innovative targeted therapies. We underscore the potential of a comprehensive treatment approach in managing recurrent pediatric MDS.
Full text:
1
Database:
MEDLINE
Language:
En
Journal:
Clin Case Rep
Year:
2023
Type:
Article